SCHEMBL13905723

SCHEMBL13905723

Nc1cc(Cl)cc(S(=O)(=O)Nc2cccc3ccccc23)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.60
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
ALDH1A1 P00352 1/20 0.53
MAPT P10636 1/20 0.53
KEAP1 Q14145 2/20 0.48
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
ALOX12 P18054 1/20 0.46
SLC40A1 Q9NP59 1/20 0.45
HTR1A P08908 1/20 0.44
HTR2A P28223 1/20 0.44
HTR7 P34969 1/20 0.44
HTR6 P50406 1/20 0.44
PIK3CD O00329 1/20 0.43
PIK3CG P48736 1/20 0.43
MCL1 Q07820 1/20 0.43
ACLY P53396 1/20 0.43
HKDC1 Q2TB90 1/20 0.43
NFE2L2 Q16236 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1319104 0.90 RECQL (0.69) RECQLKMT2AMEN1ALDH1A1MAPT
SCHEMBL1319752 0.84 RECQL (0.60) RECQLKMT2AMEN1ALDH1A1MAPT
SCHEMBL2055420 0.84 RECQL (0.60) RECQLKMT2AMEN1ALDH1A1MAPT
SCHEMBL2055417 0.84 RECQL (0.60) RECQLKMT2AMEN1ALDH1A1MAPT
SCHEMBL2055434 0.81 ACLY (0.58) RECQLKMT2AMEN1ALDH1A1MAPT
SCHEMBL2055427 0.81 ACLY (0.58) RECQLKMT2AMEN1ALDH1A1MAPT
SCHEMBL164503 0.80 RECQL (0.76) RECQLKMT2AMEN1ALDH1A1MAPT
SCHEMBL2098718 0.80 RECQL (0.55) RECQLKMT2AMEN1ALDH1A1MAPT
SCHEMBL1110445 0.79 KEAP1 (0.49) RECQLKEAP1ACLYHKDC1NFE2L2
SCHEMBL2055418 0.79 RECQL (0.69) RECQLKMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009030715-A1 ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-12 WO disclosed